Xampla is collaborating with Britvic to develop vitamin microcapsules that may be mircopackaged in beverages without affecting the taste and the risk of degradation during transit and storage.
A microscopic droplet of vitamin oil wrapped in a plant-based material protects the vitamin, such as vitamin D, from ultra-violet light, pH imbalance, and pasteurization.
The vitamin microcapsules, according to Xampla, "increase the volume of effective vitamins without affecting the product's taste."
Any oil-based vitamin or flavor, including vitamins A, D, E, and K, can be packaged using this technology.
Simon Hombersley, CEO of Xampla, described their product as microcapsules that “offer an opportunity for big beverage brands to get the vitamins people need directly to them inside everyday products”.
He added that the vitamin microcapsule provides a much-needed, simple solution for brands to infuse vitamin D safely in clear bottles, as well as the potential to micropackage a whole range of other nutrients in the future.
Xampia is working with multi-nationals to bring this product to supermarket shelves.


UK Retail Sales Rise as World Cup and Heatwave Boost Food, Pubs and Clothing
AstraZeneca Q2 Earnings Beat Forecasts as Oncology Growth Supports 2026 Outlook
Anthropic Signs $9.1B AI Data Center Deal With Riot Platforms
Asian Stocks Rise as Weak US Jobs Data Eases Fed Rate Hike Fears
Singapore Raises 2026 GDP Growth Forecast as AI Demand Fuels Economy
Trump Media Says Truth API Draws 10+ Customers as Conflict Concerns Grow
France Keeps Top Health Alert as Officials Brace for Another Heatwave
Oil Prices Rise as US-Iran Talks Stall, Inflation Risks Grow
UOB Q2 Net Profit Rises 10% as Wealth Management Growth Boosts Earnings
CDC Expands Ebola Screening Efforts at U.S. Entry Points Amid Congo and Uganda Outbreak
US Plans Kenya Ebola Quarantine Facility Amid Congo Outbreak
US Tightens Ebola Controls as Congo Outbreak Sparks Global Concern
Nvidia to Invest Up to $3 Billion in Blackstone-Backed Lancium
US Dollar Near Two-Month Low as Markets Await Inflation Data
GSK Unveils $2.52 Billion Cost-Cutting Plan to Accelerate Drug Pipeline
Alibaba Plans Revenue-Sharing Model for Qwen3.8-Max AI Commercial Users 



